Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.
about
Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Cost effectiveness of regorafe ...... nced hepatocellular carcinoma.
@en
type
label
Cost effectiveness of regorafe ...... nced hepatocellular carcinoma.
@en
prefLabel
Cost effectiveness of regorafe ...... nced hepatocellular carcinoma.
@en
P2860
P356
P1433
P1476
Cost effectiveness of regorafe ...... anced hepatocellular carcinoma
@en
P2093
Amit G Singal
David W Hutton
P2860
P304
P356
10.1002/CNCR.30863
P407
P577
2017-06-29T00:00:00Z